Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.
J Clin Pharmacol. 2001 Mar;41(3):305-16. doi: 10.1177/00912700122010122.
J Clin Pharmacol. 2001.
PMID: 11269571
Clinical Trial.
Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
Stevens JC, Fayer JL, Cassidy KC.
Stevens JC, et al. Among authors: fayer jl.
Drug Metab Dispos. 2001 Mar;29(3):289-95.
Drug Metab Dispos. 2001.
PMID: 11181497
Item in Clipboard
A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro.
Fayer JL, Petullo DM, Ring BJ, Wrighton SA, Ruterbories KJ.
Fayer JL, et al.
J Pharmacol Toxicol Methods. 2001 Sep-Oct;46(2):117-23. doi: 10.1016/s1056-8719(02)00168-5.
J Pharmacol Toxicol Methods. 2001.
PMID: 12481849
Item in Clipboard
Cite
Cite